Pulmonary retention of free and liposome-encapsulated tobramycin after intratracheal administration in uninfected rats and rats infected with Pseudomonas aeruginosa

scientific article published on May 1994

Pulmonary retention of free and liposome-encapsulated tobramycin after intratracheal administration in uninfected rats and rats infected with Pseudomonas aeruginosa is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1128/AAC.38.5.1090
P932PMC publication ID188155
P698PubMed publication ID8067743
P5875ResearchGate publication ID15130991

P2093author name stringMontplaisir S
Sharkawi M
Lagacé J
Omri A
Beaulac C
Bouhajib M
P2860cites workMicro-determination of tobramycin in serum by high-performance liquid chromatography with ultraviolet detectionQ70976303
Micro determination of gentamicin in serum by high-performance liquid chromatography with ultraviolet detectionQ71213469
Controlled delivery of an antitumor drug: localized action of liposome encapsulated cytosine arabinoside administered via the respiratory systemQ71244575
Endobronchial pH. Relevance of aminoglycoside activity in gram-negative bacillary pneumoniaQ71730810
Microbiology of cystic fibrosis lung infections: themes and issuesQ72082088
Protection against pulmonary oxygen toxicity in rats by the intratracheal administration of liposome-encapsulated superoxide dismutase or catalaseQ93589397
Production of mucoid microcolonies by Pseudomonas aeruginosa within infected lungs in cystic fibrosisQ33903005
Comparative properties and methods of preparation of lipid vesicles (liposomes).Q34275078
Double-blind study of endotracheal tobramycin in the treatment of gram-negative bacterial pneumonia. The Endotracheal Tobramycin Study GroupQ35248679
In vitro activity of piperacillin, ticarcillin, and mezlocillin alone and in combination with aminoglycosides against Pseudomonas aeruginosaQ35574121
Outer membrane permeability in Pseudomonas aeruginosa: comparison of a wild-type with an antibiotic-supersusceptible mutantQ35673789
Permeability of Pseudomonas aeruginosa outer membrane to hydrophilic solutes.Q36407886
Pseudomonas aeruginosa and cystic fibrosis: unusual bacterial adaptation and pathogenesis.Q39613399
A rat model of chronic respiratory infection with Pseudomonas aeruginosaQ39663990
Tissue penetration of antibioticsQ39733571
Aminoglycoside antibiotics in infectious diseases. An overviewQ39738119
The influence of vesicle membrane properties on the interaction of lipid vesicles with cultured cellsQ39773523
Bronchial Tree Penetration of AntibioticsQ40149327
The pathogenesis and treatment of pulmonary infections in patients with cystic fibrosisQ40299053
Penetration of antibiotics into respiratory secretions.Q40304195
The Concentration of Tobramycin in Bronchial SecretionsQ41032685
Lung Uptake of Liposome-entrapped Glutathione After Intratracheal AdministrationQ43618690
An epidemic spread of multiresistant Pseudomonas aeruginosa in a cystic fibrosis centreQ44021808
Is anti-Pseudomonas therapy warranted in acute respiratory exacerbations in children with cystic fibrosis?Q44379999
The effect of liposomal cefoperazone against Pseudomonas aeruginosa in a granulocytopenic mouse model of acute lung infectionQ44861655
Cystic fibrosis survival rates. The influences of allergy and Pseudomonas aeruginosaQ45137682
Localization of alveolar surfactant clearance in rabbit lung cellsQ46075856
Uptake of liposomes by cultured mouse bone marrow macrophages: influence of liposome composition and sizeQ47434536
Pharmacokinetic evaluation of tobramycin in the alveolar lining fluid of the rat after endotracheal administrationQ49121682
The penetration of aminoglycosides into the alveolar lining fluid of rats. The effect of airway inflammationQ49125375
Drug-induced ototoxicity.Q50605940
Enhanced liposome-mediated antibacterial activity of piperacillin and gentamicin against gram-negative bacilli in vitro.Q54375838
Renal parenchymal accumulation of aminoglycoside antibiotics in ratsQ56983379
Pseudomonas aeruginosa infection in cystic fibrosis. Diagnostic and prognostic significance of pseudomonas aeruginosa precipitins determined by means of crossed immunoelectrophoresis. A surveyQ66902144
Cystic fibrosisQ67485363
Disposition of drugs in cystic fibrosis. III. AcetaminophenQ67781829
Liposome-encapsulated antibiotics: preparation, drug release and antimicrobial activity against Pseudomonas aeruginosaQ67996392
Liposomal pulmonary drug delivery. I. In vivo disposition of atropine base in solution and liposomal form following endotracheal instillation to the rabbit lungQ69681435
The nephropathy of cystic fibrosis: a human model of chronic nephrotoxicityQ70480733
Disposition of liposomal gentamicin following intrabronchial administration in rabbitsQ70590954
Pulmonary delivery of free and liposomal insulinQ70618580
Improved microdetermination of gentamicin and sisomicin in serum by high-performance liquid chromatography with ultraviolet detectionQ70830019
P433issue5
P407language of work or nameEnglishQ1860
P921main subjectPseudomonas aeruginosaQ31856
P304page(s)1090-1095
P577publication date1994-05-01
P1433published inAntimicrobial Agents and ChemotherapyQ578004
P1476titlePulmonary retention of free and liposome-encapsulated tobramycin after intratracheal administration in uninfected rats and rats infected with Pseudomonas aeruginosa
P478volume38